位置:首页 > 蛋白库 > UBD_MOUSE
UBD_MOUSE
ID   UBD_MOUSE               Reviewed;         162 AA.
AC   P63072; Q4FJZ5; Q9WV10;
DT   13-SEP-2004, integrated into UniProtKB/Swiss-Prot.
DT   13-SEP-2004, sequence version 1.
DT   03-AUG-2022, entry version 134.
DE   RecName: Full=Ubiquitin D;
DE   AltName: Full=Diubiquitin;
DE   AltName: Full=Ubiquitin-like protein FAT10;
GN   Name=Ubd; Synonyms=Fat10;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Yu X., Liu Y., Weissman S.M.;
RT   "Disruption of the mouse Fat10 gene by gene targeting in the mouse
RT   embryonic stem cells.";
RL   Submitted (OCT-2000) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Small intestine;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Muenstermann E., Schatten R., Henze S., Bohn E., Mollenhauer J.,
RA   Wiemann S., Schick M., Korn B.;
RT   "Cloning of mouse full open reading frames in Gateway(R) system entry
RT   vector (pDONR201).";
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Mammary gland;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION, SUBCELLULAR LOCATION, INDUCTION, AND MUTAGENESIS OF
RP   161-GLY-GLY-162.
RX   PubMed=11445583; DOI=10.1074/jbc.m105139200;
RA   Raasi S., Schmidtke G., Groettrup M.;
RT   "The ubiquitin-like protein FAT10 forms covalent conjugates and induces
RT   apoptosis.";
RL   J. Biol. Chem. 276:35334-35343(2001).
RN   [7]
RP   FUNCTION.
RX   PubMed=15831455; DOI=10.1128/mcb.25.9.3483-3491.2005;
RA   Hipp M.S., Kalveram B., Raasi S., Groettrup M., Schmidtke G.;
RT   "FAT10, a ubiquitin-independent signal for proteasomal degradation.";
RL   Mol. Cell. Biol. 25:3483-3491(2005).
RN   [8]
RP   FUNCTION.
RX   PubMed=16495380; DOI=10.1681/asn.2005070692;
RA   Ross M.J., Wosnitzer M.S., Ross M.D., Granelli B., Gusella G.L., Husain M.,
RA   Kaufman L., Vasievich M., D'Agati V.D., Wilson P.D., Klotman M.E.,
RA   Klotman P.E.;
RT   "Role of ubiquitin-like protein FAT10 in epithelial apoptosis in renal
RT   disease.";
RL   J. Am. Soc. Nephrol. 17:996-1004(2006).
RN   [9]
RP   FUNCTION, INDUCTION BY TNFA AND IFNG, DISRUPTION PHENOTYPE, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=16782901; DOI=10.1128/mcb.00966-05;
RA   Canaan A., Yu X., Booth C.J., Lian J., Lazar I., Gamfi S.L., Castille K.,
RA   Kohya N., Nakayama Y., Liu Y.-C., Eynon E., Flavell R., Weissman S.M.;
RT   "FAT10/diubiquitin-like protein-deficient mice exhibit minimal phenotypic
RT   differences.";
RL   Mol. Cell. Biol. 26:5180-5189(2006).
RN   [10]
RP   FUNCTION, AND INTERACTION WITH UBA6.
RX   PubMed=17889673; DOI=10.1016/j.molcel.2007.08.020;
RA   Chiu Y.-H., Sun Q., Chen Z.J.;
RT   "E1-L2 activates both ubiquitin and FAT10.";
RL   Mol. Cell 27:1014-1023(2007).
RN   [11]
RP   INDUCTION BY DRUG INJURY.
RX   PubMed=18280469; DOI=10.1016/j.yexmp.2007.12.003;
RA   Oliva J., Bardag-Gorce F., French B.A., Li J., McPhaul L., Amidi F.,
RA   Dedes J., Habibi A., Nguyen S., French S.W.;
RT   "Fat10 is an epigenetic marker for liver preneoplasia in a drug-primed
RT   mouse model of tumorigenesis.";
RL   Exp. Mol. Pathol. 84:102-112(2008).
RN   [12]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=19959714; DOI=10.1681/asn.2009050479;
RA   Gong P., Canaan A., Wang B., Leventhal J., Snyder A., Nair V., Cohen C.D.,
RA   Kretzler M., D'Agati V., Weissman S., Ross M.J.;
RT   "The ubiquitin-like protein FAT10 mediates NF-kappa-B activation.";
RL   J. Am. Soc. Nephrol. 21:316-326(2010).
CC   -!- FUNCTION: Ubiquitin-like protein modifier which can be covalently
CC       attached to target protein and subsequently leads to their degradation
CC       by the 26S proteasome, in a NUB1-dependent manner. Probably functions
CC       as a survival factor. Promotes the expression of the proteasome subunit
CC       beta type-9 (PSMB9/LMP2). Regulates TNF-alpha-induced and LPS-mediated
CC       activation of the central mediator of innate immunity NF-kappa-B by
CC       promoting TNF-alpha-mediated proteasomal degradation of ubiquitinated-
CC       I-kappa-B-alpha. Required for TNF-alpha-induced p65 nuclear
CC       translocation in renal tubular epithelial cells (RTECs). May be
CC       involved in dendritic cell (DC) maturation, the process by which
CC       immature dendritic cells differentiate into fully competent antigen-
CC       presenting cells that initiate T-cell responses. Mediates mitotic non-
CC       disjunction and chromosome instability, in long-term in vitro culture
CC       and cancers, by abbreviating mitotic phase and impairing the
CC       kinetochore localization of MAD2L1 during the prometaphase stage of the
CC       cell cycle. May be involved in the formation of aggresomes when
CC       proteasome is saturated or impaired. Mediates apoptosis in a caspase-
CC       dependent manner, especially in renal epithelium and tubular cells
CC       during renal diseases. {ECO:0000269|PubMed:11445583,
CC       ECO:0000269|PubMed:15831455, ECO:0000269|PubMed:16495380,
CC       ECO:0000269|PubMed:16782901, ECO:0000269|PubMed:17889673,
CC       ECO:0000269|PubMed:19959714}.
CC   -!- SUBUNIT: Interacts directly with the 26S proteasome. The interaction
CC       with NUB1 via the N-terminal ubiquitin domain facilitates the linking
CC       of UBD-conjugated target protein to the proteasome complex and
CC       accelerates its own degradation and that of its conjugates. Interacts
CC       (via ubiquitin-like 1 domain) with the spindle checkpoint protein
CC       MAD2L1 during mitosis. Present in aggresomes of proteasome inhibited
CC       cells. Interacts with HDAC6 under proteasome impairment conditions (By
CC       similarity). Forms a thioester with UBA6 in cells stimulated with tumor
CC       necrosis factor-alpha (TNFa) and interferon-gamma (IFNg)
CC       (PubMed:17889673). Interacts with SQSTM1 and TP53/p53 (By similarity).
CC       {ECO:0000250|UniProtKB:O15205, ECO:0000269|PubMed:17889673}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:11445583}. Cytoplasm
CC       {ECO:0000269|PubMed:11445583}. Note=Accumulates in aggresomes under
CC       proteasome inhibition conditions. {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Mostly expressed in thymus and intestine.
CC       {ECO:0000269|PubMed:16782901}.
CC   -!- INDUCTION: Rapidly degraded by the proteasome. Cell-cycle regulation
CC       with highest expression during the S-phase (at protein level). Over
CC       expressed in hepatocytes by drug injury (e.g. DDC; diethyl 1,4-dihydro-
CC       2,4,6-trimethyl-3,5-pyridinedicarboxylate). Inducible by the pro-
CC       inflammatory cytokines tumor necrosis factor-alpha (TNFa) and
CC       interferon-gamma (IFNg). {ECO:0000269|PubMed:11445583,
CC       ECO:0000269|PubMed:16782901, ECO:0000269|PubMed:18280469}.
CC   -!- PTM: Can be acetylated. {ECO:0000250}.
CC   -!- DISRUPTION PHENOTYPE: Spontaneous sporadic apoptotic death. Higher
CC       sensitivity toward endotoxin challenge. Abrogated TNF-alpha-induced NF-
CC       kappa-B activation and reduced induction of NF-kappa-B-regulated genes.
CC       Impaired TNF-alpha-induced I-kappa-B-alpha degradation and nuclear
CC       translocation of p65 in RTECs. Reduced expression of LMP2.
CC       {ECO:0000269|PubMed:16782901, ECO:0000269|PubMed:19959714}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF314088; AAG27477.1; -; Genomic_DNA.
DR   EMBL; AK008116; BAB25471.1; -; mRNA.
DR   EMBL; AK008552; BAB25738.1; -; mRNA.
DR   EMBL; CT010257; CAJ18465.1; -; mRNA.
DR   EMBL; AL078630; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC027627; AAH27627.2; -; mRNA.
DR   EMBL; BC036383; AAH36383.1; -; mRNA.
DR   CCDS; CCDS28737.1; -.
DR   RefSeq; NP_075626.1; NM_023137.3.
DR   AlphaFoldDB; P63072; -.
DR   SMR; P63072; -.
DR   BioGRID; 204900; 1.
DR   MINT; P63072; -.
DR   STRING; 10090.ENSMUSP00000035808; -.
DR   iPTMnet; P63072; -.
DR   PhosphoSitePlus; P63072; -.
DR   PaxDb; P63072; -.
DR   PRIDE; P63072; -.
DR   Antibodypedia; 25984; 318 antibodies from 37 providers.
DR   DNASU; 24108; -.
DR   Ensembl; ENSMUST00000038844; ENSMUSP00000035808; ENSMUSG00000035186.
DR   GeneID; 24108; -.
DR   KEGG; mmu:24108; -.
DR   UCSC; uc008cmi.2; mouse.
DR   CTD; 10537; -.
DR   MGI; MGI:1344410; Ubd.
DR   VEuPathDB; HostDB:ENSMUSG00000035186; -.
DR   eggNOG; KOG0001; Eukaryota.
DR   GeneTree; ENSGT00910000144359; -.
DR   HOGENOM; CLU_139252_0_0_1; -.
DR   InParanoid; P63072; -.
DR   OMA; ETQIVTC; -.
DR   OrthoDB; 1377739at2759; -.
DR   PhylomeDB; P63072; -.
DR   Reactome; R-MMU-8951664; Neddylation.
DR   BioGRID-ORCS; 24108; 2 hits in 76 CRISPR screens.
DR   ChiTaRS; Ubd; mouse.
DR   PRO; PR:P63072; -.
DR   Proteomes; UP000000589; Chromosome 17.
DR   RNAct; P63072; protein.
DR   Bgee; ENSMUSG00000035186; Expressed in thymus and 53 other tissues.
DR   Genevisible; P63072; MM.
DR   GO; GO:0016235; C:aggresome; ISO:MGI.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0001650; C:fibrillar center; ISO:MGI.
DR   GO; GO:0005654; C:nucleoplasm; ISO:MGI.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0070628; F:proteasome binding; ISS:UniProtKB.
DR   GO; GO:0070842; P:aggresome assembly; ISS:UniProtKB.
DR   GO; GO:0043011; P:myeloid dendritic cell differentiation; ISS:UniProtKB.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IMP:UniProtKB.
DR   GO; GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IMP:UniProtKB.
DR   GO; GO:0032446; P:protein modification by small protein conjugation; IC:UniProtKB.
DR   GO; GO:0016567; P:protein ubiquitination; IMP:UniProtKB.
DR   GO; GO:1901990; P:regulation of mitotic cell cycle phase transition; ISS:UniProtKB.
DR   GO; GO:0034341; P:response to interferon-gamma; IEP:UniProtKB.
DR   GO; GO:0034612; P:response to tumor necrosis factor; IEP:UniProtKB.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IMP:UniProtKB.
DR   InterPro; IPR000626; Ubiquitin-like_dom.
DR   InterPro; IPR029071; Ubiquitin-like_domsf.
DR   InterPro; IPR042969; Ubiquitin_D.
DR   InterPro; IPR019956; Ubiquitin_dom.
DR   PANTHER; PTHR47731; PTHR47731; 1.
DR   Pfam; PF00240; ubiquitin; 2.
DR   PRINTS; PR00348; UBIQUITIN.
DR   SMART; SM00213; UBQ; 2.
DR   SUPFAM; SSF54236; SSF54236; 2.
DR   PROSITE; PS50053; UBIQUITIN_2; 2.
PE   1: Evidence at protein level;
KW   Acetylation; Cytoplasm; Nucleus; Reference proteome; Repeat;
KW   Ubl conjugation pathway.
FT   CHAIN           1..162
FT                   /note="Ubiquitin D"
FT                   /id="PRO_0000114894"
FT   DOMAIN          3..78
FT                   /note="Ubiquitin-like 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00214"
FT   DOMAIN          87..160
FT                   /note="Ubiquitin-like 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00214"
FT   SITE            161..162
FT                   /note="Activation by thioester intermediate formation with
FT                   UBA6"
FT   MUTAGEN         161..162
FT                   /note="Missing: Impaired conjugation of target proteins."
FT                   /evidence="ECO:0000269|PubMed:11445583"
SQ   SEQUENCE   162 AA;  18376 MW;  6107D8604F96455F CRC64;
     MASVRTCVVR SDQWRLMTFE TTENDKVKKI NEHIRSQTKV SVQDQILLLD SKILKPHRKL
     SSYGIDKETT IHLTLKVVKP SDEELPLFLV ESKNEGQRHL LRVRRSSSVA QVKEMIESVT
     SVIPKKQVVN CNGKKLEDGK IMADYNIKSG SLLFLTTHCT GG
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024